Risk of venous thromboembolism (VTE) conferred by type of thrombophilia.33
| Thrombophilia . | Odds Ratios (95% CI) . |
|---|---|
| Factor V Leiden – homozygosity | 34.40 (9.86, 120.05)33 |
| Factor V Leiden – heterozygosity | 8.32 (5.44, 12.70)33 |
| Prothrombin gene mutation – homozygosity | 26.36 (1.24, 559.29)33 |
| Prothrombin gene mutation – heterozygosity | 6.80 (2.46, 18.77)33 |
| Protein C deficiency | 4.76 (2.15, 10.57)33 |
| Protein S deficiency | 2.19 (1.48, 6.00)33 |
| Antithrombin deficiency | 4.76 (2.15, 10.57) |
| Methylene tetrahydrofolate reductase C677T – homozygosity | 0.74 (0.22, 2.48)33 |
| Antiphospholipid antibodies | 15.8 (10.9, 22.8)5 |
| Thrombophilia . | Odds Ratios (95% CI) . |
|---|---|
| Factor V Leiden – homozygosity | 34.40 (9.86, 120.05)33 |
| Factor V Leiden – heterozygosity | 8.32 (5.44, 12.70)33 |
| Prothrombin gene mutation – homozygosity | 26.36 (1.24, 559.29)33 |
| Prothrombin gene mutation – heterozygosity | 6.80 (2.46, 18.77)33 |
| Protein C deficiency | 4.76 (2.15, 10.57)33 |
| Protein S deficiency | 2.19 (1.48, 6.00)33 |
| Antithrombin deficiency | 4.76 (2.15, 10.57) |
| Methylene tetrahydrofolate reductase C677T – homozygosity | 0.74 (0.22, 2.48)33 |
| Antiphospholipid antibodies | 15.8 (10.9, 22.8)5 |